Vectura Group plc is a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. Our goal is to improve patients’ lives and generate value for our stakeholders.
Press releases
07 June 2010Vectura Group plc - Preliminary Results
21 May 2010NVA237 Phase II Data at the American Thoracic Society Meeting
10 May 2010Vectura close period trading update
Latest press releases
Next events
21 September 2010Credit Suisse US Bus Tour, London
22 September 2010
Annual General Meeting, London
Investor Calendar
